Enterprise League logo

Product

CAR-T Cell Therapy

BIOTECHNOLOGY

byImmuneCyte, Inc.

United States (US)

ABOUT THE PRODUCT

ImmuneCyte is developing a next-generation CAR-T cell therapy platform targeting various cancers. This innovative approach utilizes enhanced T-cell engineering to improve efficacy and reduce side effects.

Information is owner-confirmed

Last updated 0 month ago

Price range
N/A

Other products/services from ImmuneCyte, Inc.